๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This is an efficacy and safety study to compare aprepitant with ondansetron...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-12
Trial ID
NCT01636947
This study is being done to determine the efficacies of two preventative dr...
Status
Completed
Location
The Ohio State University Wexner Medical Center
Start Date
2007-06
Trial ID
NCT01474915
Treatments Being Tested
Recent evidence suggests multiple drug therapy is superior to single agents...
Status
Completed
Location
Hahnemann University Hospital
Start Date
2008-04
Trial ID
NCT00659737
Treatments Being Tested
The purpose of this study was to determine the appropriate dosing regimen o...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-13
Trial ID
NCT01697579
Treatments Being Tested
The purpose of the study is to determine whether 40 mg aprepitant administe...
Status
Terminated
Location
Mayo Clinic
Start Date
2007-07
Trial ID
NCT00888329
Treatments Being Tested
This research study is being done to compare the effects of Aprepitant and ...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2017-01-27
Trial ID
NCT02989467
Treatments Being Tested
Title of the study Aprepitant for prevention of acute and delayed nausea an...
Status
Unknown
Location
Azienda Ospedaliera di Perugia - Hematology dept.
Start Date
2010-04
Trial ID
NCT01088022
Treatments Being Tested
This 5-part study will evaluate the safety, tolerability, and pharmacokinet...
Status
Completed
Location
Multiple Locations
Start Date
2005-01
Trial ID
NCT00990821
A clinical study to determine the efficacy and safety of MK0869 in the trea...
Status
Completed
Location
Multiple Locations
Start Date
2002-07-30
Trial ID
NCT00048607
Treatments Being Tested
This is a multicenter, randomized, controlled, double-blind, phase III stud...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2020-10-01
Trial ID
NCT04536558